ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

Stereotactic Radiosurgery Improves Survival Without Whole-Brain Radiotherapy

September 27, 2013

Modeling: Like The Sims But No Graphics

November 26, 2010

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland

October 31, 1975

In Brief: Breast Cancer Cells To Be Studied In Space; GrieshaberTo Head Drug Discovery Program

January 30, 1998